OncoMed Pharmaceuticals Inc License Agreements
13 Contracts & Agreements
- Amendment No. 3 to the Multi-Product License Agreement, dated August 26, 2016, by and between the registrant and Lonza Sales AG (Filed With SEC on November 2, 2017)
- AMENDMENT NO. 2 to the Multi-Product License Agreement dated 22 August 2012 between LONZA SALES AG and ONCOMED PHARMACEUTICALS, INC 1 (Filed With SEC on November 5, 2015)
- MULTI-PRODUCT LICENSE AGREEMENT between LONZASALES AG and ONCOMED PHARMACEUTICALS, INC. INDEX (Filed With SEC on October 25, 2012)
- SUBSCRIPTION AND LICENSE AGREEMENT (Filed With SEC on July 5, 2012)
- AMENDMENT NO. 6 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)
- AMENDMENT NO. 5 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)
- Amendment No. 4 to License Agreement between the Regents of The University of Michigan and OncoMed Pharmaceuticals,Inc. (Filed With SEC on May 11, 2012)
- AMENDMENT NO. 3 TO LICENSE AGREEMENT REGENTS OF THE UNIVERSITY OF MICHIGAN AND ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2012)
- Amendment Number 2 to License Agreement Regents of The University ofMichigan & OncoMed Pharmaceuticals, Inc. (Filed With SEC on May 11, 2012)
- Amendment Number 1 to License Agreement Regents of The University ofMichigan & Cancer Stem Cell Genomics, Inc. University of Michigan Files 1819, 1876, 1980, 2237, 2629, 2705 (Filed With SEC on May 11, 2012)
- LICENSE AGREEMENT WITH CANCER STEM CELL GENOMICS, INC. MICHIGAN FILES 1819, 1876 AND 1980 TECHNOLOGY (Filed With SEC on May 11, 2012)
- APPENDIX 4.3(a) COMMERCIAL LICENSE REQUEST FORM (To be completed for each Commercial Target) (Filed With SEC on May 11, 2012)
- SUBSCRIPTION AND LICENSE AGREEMENT (Filed With SEC on May 11, 2012)
